K-Laser Class IV therapeutic lasers deliver specific red and near-infrared wavelengths of laser light to induce a photochemical reaction and therapeutic effect. Physiological effects include increased circulation, reduced inflammation, pain reduction and enhanced tissue healing. Laser therapy has been used in Europe since the 1970s and was cleared by the United States Food and Drug Administration (FDA) in 2005.
Plasma is the liquid within which the other components of blood, such as red blood cells and platelets, are suspended. It is mostly comprised of water. Platelets are small fragments of cells that play a role in the blood clotting process and also promote healing.
Platelet-rich plasma (PRP) is derived from the patient’s own blood. Veterinarians process the plasma so that it has a higher-than-usual concentration of platelets. The plasma contains growth factors and proteins that accelerate the healing of tendons and ligaments and may promote regeneration of cartilage or bone.
PRP injections can decrease pain associated with arthritis by reducing inflammation in the joints. They may also help tendon or ligament injuries heal. Patients with chronic, slow, or non-healing wounds may also benefit from PRP.
Platelets are a cell-like component of blood and are primarily responsible for the development of clots. Platelets also contain a remarkable array of growth factors involved in healing. The list includes platelet-derived growth factors (PDGF), ß-thromboglobulin, fibroblast growth factor, insulin-like growth factor 1, epidermal growth factor, and vascular endothelial growth factor. These growth factors are primarily responsible for the recruitment and differentiation of progenitor cells; promoting angiogenesis, new tissue growth, and replenishing the extracellular matrix.